His primary areas of investigation include Biochemistry, Peroxisome, Endocrinology, Internal medicine and Cytochrome P450. His Biochemistry study frequently draws connections to adjacent fields such as Cruciferous vegetables. His work on Peroxisome Proliferation and Nafenopin as part of his general Peroxisome study is frequently connected to Carnitine O-acetyltransferase, thereby bridging the divide between different branches of science.
His Endocrinology research is multidisciplinary, incorporating perspectives in Receptor, Ciprofibrate, Phthalate and Toxicity. His research in Cytochrome P450 intersects with topics in Microsome, Isozyme and Pharmacology. His Microsome research is multidisciplinary, relying on both Enzyme inducer and Hydroxylation.
Brian G. Lake mainly focuses on Biochemistry, Endocrinology, Internal medicine, Cytochrome P450 and Microsome. As part of his studies on Biochemistry, he often connects relevant areas like Toxicity. His Endocrinology study combines topics from a wide range of disciplines, such as Peroxisome, Phthalate, Peroxisome Proliferation and Hepatocyte.
His studies in Internal medicine integrate themes in fields like Mechanism of action and Carcinogen. His Cytochrome P450 research is multidisciplinary, incorporating elements of Isozyme and Enzyme inducer. His Microsome study combines topics in areas such as Cytochrome, Oxidase test and Hydroxylation.
Brian G. Lake mostly deals with Constitutive androstane receptor, Cytochrome P450, Internal medicine, Endocrinology and Hepatocyte. Cytochrome P450 is a subfield of Biochemistry that Brian G. Lake investigates. The concepts of his Biochemistry study are interwoven with issues in Cruciferous vegetables and 1h nmr spectroscopy.
His Internal medicine study incorporates themes from Cancer research and Permethrin. His Permethrin research is multidisciplinary, incorporating elements of Adenoma, Cis–trans isomerism, Microsome, Programmed cell death and Metabolism. His studies in Hepatocyte integrate themes in fields like Liver tumor and Phenobarbital.
His primary scientific interests are in Constitutive androstane receptor, Pharmacology, DNA synthesis, Carcinogen and Cytochrome P450. Brian G. Lake has included themes like Mouse bioassay, Cancer and Bioinformatics in his Pharmacology study. He combines subjects such as Lung, Hyperplasia and Genotoxicity with his study of Carcinogen.
His Cytochrome P450 study is concerned with Metabolism in general. As a part of the same scientific family, Brian G. Lake mostly works in the field of Hepatocyte, focusing on Cell growth and, on occasion, Endocrinology, Internal medicine, Permethrin, Adenoma and Programmed cell death. His work on Endocrinology is being expanded to include thematically relevant topics such as Pharmacokinetics.
This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.
A Cancer Risk Assessment of Di(2-ethylhexyl)phthalate: Application of the New U.S. EPA Risk Assessment Guidelines
John Doull;Russell Cattley;Cliff Elcombe;Brian G. Lake.
Regulatory Toxicology and Pharmacology (1999)
Scaling factors for the extrapolation of in vivo metabolic drug clearance from in vitro data: reaching a consensus on values of human microsomal protein and hepatocellularity per gram of liver.
Zoe E Barter;Martin K Bayliss;Philip H Beaune;Alan R Boobis.
Current Drug Metabolism (2007)
Do Peroxisome Proliferating Compounds Pose a Hepatocarcinogenic Hazard to Humans
Russell C. Cattley;John DeLuca;Cliff Elcombe;Penelope Fenner-Crisp.
Regulatory Toxicology and Pharmacology (1998)
Studies on the hepatic effects of orally administered di-)2-ethylhexyl) phthalate in the rat.
B.G. Lake;S.D. Gangolli;P. Grasso;A.G. Lloyd.
Toxicology and Applied Pharmacology (1975)
Peroxisome proliferation and nongenotoxic carcinogenesis: Commentary on a symposium
David E. Moody;Janardan K. Reddy;Brian G. Lake;James A. Popp.
Toxicological Sciences (1991)
Peroxisome proliferation in primary cultures of rat hepatocytes
Tim J.B. Gray;Brian G. Lake;Jenny A. Beamand;John R. Foster.
Toxicology and Applied Pharmacology (1983)
Mode of action and human relevance analysis for nuclear receptor-mediated liver toxicity: A case study with phenobarbital as a model constitutive androstane receptor (CAR) activator
Clifford R. Elcombe;Richard C. Peffer;Douglas C. Wolf;Jason Bailey.
Critical Reviews in Toxicology (2014)
Identification of cytochrome P-450 isoforms responsible for cis-tramadol metabolism in human liver microsomes.
Vangala Subrahmanyam;Anthony B. Renwick;David G. Walters;Philip J. Young.
Drug Metabolism and Disposition (2001)
Microsomal cytochrome P-452 induction and peroxisome proliferation by hypolipidaemic agents in rat liver. A mechanistic inter-relationship.
Raj Sharma;Brian G. Lake;John Foster;G. Gordon Gibson.
Biochemical Pharmacology (1988)
The in vitro hydrolysis of some phthalate diesters by hepatic and intestinal preparations from various species.
Brian G. Lake;John C. Phillips;John C. Linnell;Sharat D. Gangolli.
Toxicology and Applied Pharmacology (1977)
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below: